BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11440386)

  • 1. Clinical relevance of CagA-specific antibodies related to CagA status of Helicobacter pylori isolates using immunofluorescence test and PCR.
    Krausse R; Garten L; Harder T; Ullmann U; Birkner T; Doniec M; Grimm H
    Infection; 2001; 29(3):154-8. PubMed ID: 11440386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic diversity and serotypes of Helicobacter pylori associated with peptic ulcer diseases.
    Park SM; Hong SI; Jung HY; Yang SK; Kim HR; Min YI; Hong WS
    Korean J Intern Med; 1998 Jul; 13(2):104-9. PubMed ID: 9735665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis.
    Go MF; Graham DY
    Helicobacter; 1996 Jun; 1(2):107-11. PubMed ID: 9398887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic detection of infection with cagA+ Helicobacter pylori strains.
    Cover TL; Glupczynski Y; Lage AP; Burette A; Tummuru MK; Perez-Perez GI; Blaser MJ
    J Clin Microbiol; 1995 Jun; 33(6):1496-500. PubMed ID: 7650174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.
    Harris PR; Godoy A; Arenillas S; Riera F; García D; Einisman H; Peña A; Rollán A; Duarte I; Guiraldes E; Perez-Perez G
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):596-602. PubMed ID: 14581804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic detection of Helicobacter pylori infection with cagA-positive strains in duodenal ulcer, gastric cancer, and asymptomatic gastritis.
    Miehlke S; Go MF; Kim JG; Graham DY; Figura N
    J Gastroenterol; 1998; 33 Suppl 10():18-21. PubMed ID: 9840011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic proteins of Helicobacter pylori of potential diagnostic value.
    Khalilpour A; Santhanam A; Wei LC; Saadatnia G; Velusamy N; Osman S; Mohamad AM; Noordin R
    Asian Pac J Cancer Prev; 2013; 14(3):1635-42. PubMed ID: 23679248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis.
    Warburton VJ; Everett S; Mapstone NP; Axon AT; Hawkey P; Dixon MF
    J Clin Pathol; 1998 Jan; 51(1):55-61. PubMed ID: 9577374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and typing of the virulence determinants cagA and vacA of Helicobacter pylori directly from biopsy DNA: are in vitro strains representative of in vivo strains?
    Gunn MC; Stephens JC; Stewart JD; Rathbone BJ
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):683-7. PubMed ID: 9744698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping of Helicobacter pylori strains from gastric biopsies by multiplex polymerase chain reaction. How advantageous is it?
    Bolek BK; Salih BA; Sander E
    Diagn Microbiol Infect Dis; 2007 May; 58(1):67-70. PubMed ID: 17300903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
    Graham DY; Genta RM; Graham DP; Crabtree JE
    J Clin Pathol; 1996 Oct; 49(10):829-32. PubMed ID: 8943750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass response to Helicobacter pylori and CagA antigens in children.
    Dzierzanowska-Fangrat K; Raeiszadeh M; Dzierzanowska D; Gladkowska-Dura M; Celinska-Cedro D; Crabtree JE
    Clin Exp Immunol; 2003 Dec; 134(3):442-6. PubMed ID: 14632749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori population characteristic in patients with diseases of gastrointestinal tract].
    Zhebrun AB; Svarval' AV; Balabash OA; Ferman RS
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (2):90-6. PubMed ID: 23805678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori.
    Son HJ; Rhee JC; Park DI; Kim YH; Rhee PL; Koh KC; Paik SW; Choi KW; Kim JJ
    Helicobacter; 2001 Mar; 6(1):37-43. PubMed ID: 11328364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Helicobacter pylori DNA in gastric juice by the polymerase chain reaction: comparison with findings in bacterial culture and the detection of tissue IgA and serum IgG antibodies against Helicobacter pylori.
    Matsukura N; Onda M; Tokunaga A; Kato S; Yamashita K; Ohbayashi M
    J Gastroenterol; 1995 Dec; 30(6):689-95. PubMed ID: 8963384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional study.
    Filipec Kanizaj T; Katicić M; Presecki V; Gasparov S; Colić Cvrlje V; Kolarić B; Mrzljak A
    Croat Med J; 2009 Apr; 50(2):124-32. PubMed ID: 19399945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.
    Sezikli M; Guliter S; Apan TZ; Aksoy A; Keles H; Ozkurt ZN
    Int J Clin Pract; 2006 Oct; 60(10):1239-43. PubMed ID: 16669834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
    Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.